Stocktoria

GLAUKOS Corp GKOS

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2015-06-25 · LEI

GLAUKOS Corp financials (annual)

Revenue
$114.4M $159.3M $181.3M $237.0M $225.0M $294.0M $282.9M $314.7M $383.5M $507.4M 2016201720182019202020212022202320242025
Net income
$4.5M -$92000 -$13.0M $15.4M -$120.3M -$49.6M -$99.2M -$134.7M -$146.4M -$187.7M 2016201720182019202020212022202320242025
Free cash flow
$6.0M $19.8M $8.5M -$5.1M -$29.9M -$23.1M -$63.3M -$78.0M -$67.6M -$22.5M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$507.4M$383.5M$314.7M$282.9M$294.0M$225.0M$237.0M$181.3M$159.3M$114.4M
Gross profit$282.8M$289.5M$239.1M$213.9M$227.4M$133.2M$198.4M$156.2M$138.2M$98.2M
R&D expense$49.7M$38.9M$29.2M
SG&A expense$331.7M$261.2M$224.1M$192.9M$179.3M$171.4M$176.6M$119.5M$96.3M$64.8M
Operating income-$199.6M-$122.4M-$128.7M-$82.3M-$32.9M-$123.6M-$50.3M-$13.0M-$2.3M$4.2M
Interest expense$13.6M$13.7M$13.4M$14.1M$2.6M
Income tax-$5.4M$771,000$934,000$766,000$326,000-$12.0M-$65.5M$583,000$93,000$43,000
Net income-$187.7M-$146.4M-$134.7M-$99.2M-$49.6M-$120.3M$15.4M-$13.0M-$92,000$4.5M
EPS (diluted)$-3.28$-2.77$-2.78$-2.09$-1.07$-2.70$0.37$-0.37$0.00$0.12
Operating cash flow-$14.8M-$61.3M-$57.8M-$33.1M$24.7M-$23.0M-$369,000$18.9M$26.1M$12.3M
Free cash flow-$22.5M-$67.6M-$78.0M-$63.3M-$23.1M-$29.9M-$5.1M$8.5M$19.8M$6.0M
Cash & equivalents$90.8M$169.6M$93.5M$119.5M$100.7M$96.6M$62.4M$29.8M$24.5M$6.5M
Inventory$63.6M$57.7M$42.0M$37.8M$23.0M$15.8M$42.6M$13.3M$11.2M$6.8M
Total assets$893.5M$974.8M$940.4M$1.0B$1.0B$1.0B$818.4M$207.0M$165.8M$134.4M
Total liabilities$237.3M$207.8M$478.6M$472.4M$462.5M$338.1M$145.1M$33.1M$27.6M$17.1M
Shareholders' equity$656.2M$766.9M$461.8M$530.0M$587.2M$667.4M$673.3M$173.9M$138.2M$117.3M

Growth · year-over-year · Revenue CAGR 18%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+32.3%+21.9%+11.3%-3.8%+30.7%-5.1%+30.7%+13.8%+39.2%+59.5%
Net income growth-880.3%-102.0%
EPS growth-829.7%-100.0%
Free cash flow growth-159.6%-56.8%+228.0%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.